TSE:REUN Reunion Neuroscience (REUN) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day RangeC$1.42▼C$1.4252-Week Range N/AVolume339 shsAverage Volume12,447 shsMarket CapitalizationC$16.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Reunion Neuroscience alerts: Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Reunion Neuroscience Stock (TSE:REUN)Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.Read More Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here REUN Stock News HeadlinesAugust 5, 2023 | theglobeandmail.comClosing Bell: Reunion Neuroscience Inc flat on Wednesday (REUN)August 1, 2023 | finance.yahoo.comReunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of ArrangementJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 16, 2023 | theglobeandmail.comReunion Neuroscience: Stocks Overvalued by Analyst Consensus on TSX (REUN)July 14, 2023 | finance.yahoo.comReunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of ArrangementJuly 13, 2023 | marketwatch.comReunion Neuroscience Shareholders Agree to $13.1M Sale to MPM BioImpactJuly 13, 2023 | finance.yahoo.comReunion Neuroscience Inc. Shareholders Approve Proposed Plan of ArrangementJune 2, 2023 | finance.yahoo.comWhat's Going On With Reunion Neuroscience Stock TodayJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.June 1, 2023 | msn.comReunion Neuroscience Explodes Higher on Buyout DealJune 1, 2023 | msn.comReunion Neuroscience Announces $13.1M Take-Private Transaction With Biotech Investment FirmJune 1, 2023 | technews.tmcnet.comREUN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Reunion Neuroscience Inc. Is Fair to ShareholdersApril 25, 2023 | benzinga.comReunion Neuroscience Enters Compliance Period, Struggles To Remain NASDAQ ListedMarch 27, 2023 | finance.yahoo.comReunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual MeetingMarch 3, 2023 | foxnews.com‘Jeopardy!” contestant tells Mayim Bialik that she was his childhood crush: ‘You haven’t aged a day!’February 22, 2023 | msn.comThe first-ever ‘Jeopardy!’ High School Reunion is packed with New EnglandersFebruary 14, 2023 | markets.businessinsider.comEF Hutton Reaffirms Their Buy Rating on Reunion Neuroscience (REUN)February 2, 2023 | finance.yahoo.comReunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ETSee More Headlines Receive REUN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Reunion Neuroscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:REUN CUSIPN/A CIKN/A Webwww.fieldtriphealth.com Phone888-519-6016FaxN/AEmployees16Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($3.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-38,100,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-86.35% Return on Assets-26.50% Debt Debt-to-Equity RatioN/A Current Ratio3.52 Quick RatioN/A Sales & Book Value Annual SalesC$4.86 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueC$1.82 per share Price / BookN/AMiscellaneous Outstanding Shares11,720,000Free FloatN/AMarket CapC$16.64 million OptionableNot Optionable Beta4.20 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Hannan Fleiman (Age 42)Co-Founder & Non-Independent Director Comp: $282.64kDr. Nathan Bryson B.Sc. (Age 59)Ph.D., Chief Science Officer Comp: $411.37kMr. Gregory T. Mayes Esq. (Age 54)J.D., Pres, CEO & Director Mr. Edward F. Smith CPA (Age 52)Chief Financial Officer Mr. Curtis WeberGen. CounselMr. Stephan CoteHead of QualityDr. Robert Alexander M.D.Chief Medical Officer & Sr. AdvisorMore ExecutivesKey CompetitorsPediapharmCVE:PDPHelix BioPharmaTSE:HBPEmerald Health TherapeuticsCVE:EMHCovalon TechnologiesCVE:COVProMIS NeurosciencesTSE:PMNView All Competitors REUN Stock Analysis - Frequently Asked Questions How do I buy shares of Reunion Neuroscience? Shares of REUN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:REUN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reunion Neuroscience Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reunion Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.